| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 05/03/2001 | CA2389191A1 Hygromycin derivatives |
| 05/03/2001 | CA2389019A1 Hygromycin a prodrugs |
| 05/03/2001 | CA2388077A1 Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 05/02/2001 | EP1095939A2 Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds |
| 05/02/2001 | EP1095936A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 05/02/2001 | EP1095926A2 Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate |
| 05/02/2001 | EP1095015A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 05/02/2001 | EP1094805A1 Substituted oxygen alicyclic compounds, including methods for synthesis thereof |
| 05/02/2001 | EP0988304B1 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
| 05/02/2001 | EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 05/02/2001 | EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 05/02/2001 | EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/02/2001 | CN1293672A Process for preparation of nitrofuanidine derivatives |
| 05/02/2001 | CN1293668A Process for synthesis of HTV protease inhibitors |
| 05/02/2001 | CN1293666A Benzenesulfonamide-derivatives and their use as medicaments |
| 05/02/2001 | CN1293193A Preparation of piperidyl amino methyl trifluoro methyl cyclo other compounds |
| 05/02/2001 | CN1293190A Butenolide containing no substituent at beta position and its synthesis process |
| 05/02/2001 | CN1065240C Taxanes having butenyl substituted side-chain and pharmaceutical compositions containing them |
| 05/02/2001 | CN1065237C Cyclopentane-and-cyclo pentene-beta-amino acids |
| 05/01/2001 | US6225477 Adding water soluble rhenium compound to working hydrogenation reactor during hydrogenation of maleic acid to tetrahydrofuran in aqueous medium |
| 05/01/2001 | US6225339 Terpenoid lactone compounds and their production process |
| 05/01/2001 | US6225336 For therapy of systemic mastocytosis and disorder of systemic mast cell activation as well as tracheal contraction, asthma, allergic rhinitis, allergic conjunctivitis, urticaria, ischemic reperfusion injury, and inflammation |
| 05/01/2001 | US6225334 Glyoxylic acid derivatives |
| 05/01/2001 | US6225312 Piperazine and piperidine compounds |
| 05/01/2001 | US6225073 Immunoassay for mycophenolic acid |
| 05/01/2001 | CA2317002A1 Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate |
| 04/26/2001 | WO2001029019A1 Method for preparing a benzofuran or benzothiophene compound |
| 04/26/2001 | WO2001029018A2 Novel enantiomeric compounds for treatment of cardiac arrhythmias and methods of use |
| 04/26/2001 | WO2001029017A2 N-SUBSTITUTED 3-AMINO-2,2-DI-C-ALKYL-1,4-BUTYROLACTONES AND 1,4-THIOBUTYROLACTONES FOR USE AS PROMOTER OF η-AMINOBUTYRIC ACID ACTIVITY AND FOR TREATING NERVOUS DISORDERS AND PREPARATION METHOD |
| 04/26/2001 | WO2001029013A1 Process for preparing oxazolines from tetrahydrofurans |
| 04/26/2001 | WO2001028987A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/26/2001 | WO2001028979A2 Inhibitors of neuraminidases |
| 04/26/2001 | WO2001028974A2 Intermediates for making a benzofuran or benzothiophene derivative nitrated in position 5 and uses thereof |
| 04/26/2001 | WO2001028549A1 Anti-ischemic compounds |
| 04/26/2001 | WO2000055139A3 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/26/2001 | WO2000055125A3 N-cyanomethyl amides as protease inhibitors |
| 04/26/2001 | DE19932621A1 Neue substituerte alpha, beta-anellierte Butyrolactone New substituerte alpha, beta-fused butyrolactones |
| 04/26/2001 | CA2387974A1 N-substituted 3-amino-2,2-di-c-alkyl-1,4-butyrolactones and 1,4-thiobutyrolactones for use as promoter of .gamma.-aminobutyric acid activity and for treating nervous disorders andpreparation method |
| 04/26/2001 | CA2387713A1 Intermediates for making a benzofuran or benzothiophene derivative nitrated in position 5 and uses thereof |
| 04/26/2001 | CA2387164A1 Anti-ischemic compounds |
| 04/26/2001 | CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/25/2001 | WO2000012044A2 Method for the preparation of citalopram |
| 04/25/2001 | EP1093367A1 Protease inhibitors |
| 04/25/2001 | CN1292774A Method for distilling mixtures containing butanediol |
| 04/25/2001 | CN1292375A O-acyl-alpha-hydroxycarboxylic ester compound and its preparation method |
| 04/24/2001 | US6222062 Beta-ketoester compounds |
| 04/24/2001 | US6222049 2-(ω-alkoxycarbonyl alkanoyl)-4-butanolide |
| 04/24/2001 | US6222048 Diaryl-2-(5H)-furanones as Cox-2 inhibitors |
| 04/24/2001 | US6222039 Reacting lactone compound containing nitrogen heterocycle with cyclic amine; oxidizing to form carboxylic acid group; introducing hydroxylamine group at hydroxyl of carboxylic acid group |
| 04/24/2001 | US6221911 Reducing subcutaneous fat deposits in a subject; improving the skin condition of a subject |
| 04/24/2001 | US6221904 Administering to the subject an amount of dehydroascorbic acid |
| 04/24/2001 | US6221902 Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| 04/24/2001 | US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase. |
| 04/24/2001 | US6221838 Administering an analog of an obesity protein. |
| 04/24/2001 | US6221639 Process for preparing optically pure(S)-3,4-dihydroxybutyric acid derivatives |
| 04/24/2001 | CA2085885C Alteration of rate and character of hair growth |
| 04/24/2001 | CA2078520C Trimetazidine derivatives, process for preparing same and pharmaceutical compositions containing same |
| 04/19/2001 | WO2001027098A2 Method for producing cox-2 inhibitors |
| 04/19/2001 | WO2001027097A1 Polymorphic b form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5h-furan-2-one |
| 04/19/2001 | WO2001027077A2 Hydroxysulfonylalkylene-, phosphonoalkylene- or difluoro(phosphononon)methyl- substituted benzene, or benzofuran derivatives as non-peptidic cdc25 inhibitors |
| 04/19/2001 | WO2001027068A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 04/19/2001 | WO2001027058A1 Process for the simultaneous production of maleic anhydride and its hydrogenated derivatives |
| 04/18/2001 | EP1092432A1 Anti-ischemic compounds |
| 04/18/2001 | EP1091952A1 Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer |
| 04/18/2001 | EP1091949A2 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands |
| 04/18/2001 | EP1091948A2 Tubulin binding compounds (cobra) |
| 04/18/2001 | EP1091943A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/18/2001 | EP0796254B1 Method for selectively preparing 2,5-furandicarboxaldehyde from 5-hydroxymethyl furan 2-carboxaldehyde |
| 04/18/2001 | CN1291982A Nitrate salt of anti-ulcer medicine |
| 04/18/2001 | CN1291980A thioether furan nitrone compounds |
| 04/18/2001 | CN1291973A N-sulphonyl and N-sulphinyl phenylglycinamide |
| 04/18/2001 | CN1291969A Method for selective hydrolysis of acetals or ketals in presence of 2-benzo [c] furanone |
| 04/18/2001 | CN1291468A Condensed benzene derivative used as antioxidant or free radical scavenger and its use in cosmetic preparations |
| 04/18/2001 | CN1064674C Alkoxyaryl compounds, their process of preparation and pharmaceutical compositions which contain them |
| 04/17/2001 | US6218518 For forming group ii thin films on substrates for microelectronic device applications such as integrated circuits, ferroelectric memories, switches, radiation detectors, thin-film capacitors, holographic storage |
| 04/17/2001 | US6218429 Tricyclic compounds, their production and use |
| 04/17/2001 | US6218426 For therapy of mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated |
| 04/17/2001 | US6218414 Administering an effective amount of an angiotensin ii antagonist and a benzofuran derivative with antiarrhythmic activity for therapy of cardiovascular complaints |
| 04/17/2001 | US6218413 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 04/17/2001 | US6218359 Treating autoimmune, arthritic, tumor diseases |
| 04/17/2001 | CA2196054C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 04/12/2001 | WO2001025198A1 Method for improving the solubility of tricyclic amino alcohol derivatives |
| 04/12/2001 | WO2001025197A1 Antifungal enediynes |
| 04/12/2001 | WO2001025190A1 Novel diarylamide derivatives and use thereof as medicines |
| 04/12/2001 | WO2001025189A1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds |
| 04/12/2001 | WO2001025181A1 Carboxylic acid derivatives and drugs containing the same |
| 04/12/2001 | WO2001024828A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024827A2 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO1999063939A9 Multibinding inhibitors of cyclooxygenase-2 |
| 04/12/2001 | DE19948269A1 New compounds as integrin antagonists useful for treating e.g. cardiovascular disorders, rheumatoid arthritis, kidney failure, stroke, cancer, osteoporosis, psoriasis or infection |
| 04/12/2001 | DE10041510A1 Liquid phase catalytic oxidation of organic compounds with peroxides uses catalytic complexes containing gold or silver and preferably prepared in situ |
| 04/12/2001 | CA2386457A1 Inhibitors of the endothelin signalling pathway and .alpha.v.beta.3 integrin receptor antagonists for combination therapy |
| 04/12/2001 | CA2386373A1 Method for improving the solubility of tricyclic amino alcohol derivatives |
| 04/12/2001 | CA2385972A1 Novel diarylamide derivatives and use thereof as medicines |
| 04/11/2001 | EP1090915A1 Polymorphic B form of 3-(cyclopropylmethoxy)-4-[-4-(methylsulfonyl)phenyl]- 5,5-dimethyl-5H-furan-2-one |
| 04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/11/2001 | EP1090907A1 A process for the production of amides from amines |
| 04/11/2001 | EP1090624A2 Beta ketoester |
| 04/11/2001 | EP1090557A1 Savoury flavour comprising 2-methyl-furan -3-thiol and/or a derivative and methylenedithiol and/or a derivative |
| 04/11/2001 | EP1089991A2 Process for the preparation of 3-aryl-benzofuranones |